Organization
National Pirogov Memorial Medical University, Internal Medicine, Vinnytsya, Ukraine
2 abstracts
Abstract
A PHASE III, RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED CLINICAL TRIAL TO COMPARE BAT1806/BIIB800, A PROPOSED TOCILIZUMAB BIOSIMILAR, WITH TOCILIZUMAB REFERENCE PRODUCT IN SUBJECTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE THERAPYOrg: Peking Union Medical College Hospital, Department of Rheumatology and Clinical Immunology, Beijing, China, Poznan University of Medical Sciences, Department of Rheumatology, Poznan, Poland, Clinic and Department of Rheumatology and Connective Tissue Diseases University Hospital No 2 in Bydgoszcz Collegium Medicum UMK in Toruń, Department of Rheumatology and Connective Tissue Diseases, Toruń, Poland, First Affiliated Hospital of Zhengzhou University, Department of Rheumatology and Immunology, Zhengzhou, China, Qilu Hospital of Shandong University, Department of Rheumatology, Jinan, China,
Abstract
ALEXITHYMIA IN A PATIENT WITH RHEUMATOID ARTHRITIS: CONNECTION WITH DISEASES AND FUNCTIONAL ABILITY.Org: National Pirogov Memorial Medical University, Internal Medicine, Vinnytsya, Ukraine, Department of Internal medicine №1,